Effects of high-flux hemodialysis on oxidant stress

Kidney International

Volumn 63, Issue 1, 2003, Pages 353-359

  Ward, Richard A ^a   Ouseph, Rosemary ^a   McLeish, Kenneth R ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

High flux hemodialysis; Neutrophil; Oxidant stress; Oxygen radicals; Protein oxidation

Indexed keywords

CARBONYL DERIVATIVE; CELLULOSE ACETATE; OXYGEN RADICAL; PLASMA PROTEIN; POLYSULFONE; THIOL DERIVATIVE;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MALE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0037213038     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00741.x     Document Type: Article

References (56)

1. Nath KA, Salahudeen AK, Clark EC, et al: Role of cellular metabolites in progressive renal injury. Kidney Int 42 (Suppl 38):S109-S113, 1992
2. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60:56-59, 1992
3. Maggi E, Bellazzi R, Falaschi F, et al: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45:876-883, 1994
4. Becker BN, Himmelfarb J, Henrich WL, Hakim RM: Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-486, 1997
5. Odetti P, Garibaldi S, Gurreri G, et al: Protein oxidation in hemodialysis and kidney transplantation. Metabolism 45:1319-1322, 1996
6. Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58:2571-2578, 2000
7. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al: Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335-340, 2001
8. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW: Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radical Biol Med 31:1163-1169, 2001
9. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313, 1996
10. Delmas-Beauvieux M-C, Combe C, Peuchant E, et al: Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron 69:404-410, 1995
11. Banni S, Lucchi L, Baraldi A, et al: No direct evidence of increased lipid peroxidation in hemodialysis patients. Nephron 72:177-183, 1996
12. Loughrey CM, Young IS, Lightbody JH, et al: Oxidative stress in haemodialysis. Q J Med 87:679-683, 1994
13. Köse K, Doǧan P, Gündüz Z, et al: Oxidative stress in hemodialyzed patients and the long-term effects of dialyzer reuse practice. Clin Biochem 30:601-606, 1997
14. Sutherland WHF, Walker RJ, Ball MJ, et al: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 48:227-236, 1995
15. Schulz T, Schiffl H, Scheithe R, et al: Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis 25:564-571, 1995
16. Meagher EA, FitzGerald GA: Indices of lipid peroxidation in vivo: Strengths and limitations. Free Radical Biol Med 28:1745-1750, 2000
17. Handelman GJ, Walter MF, Adhikarla R, et al: Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 59:1960-1966, 2001
18. Klein JB, McLeish KR, Ward RA: Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am J Kidney Dis 33:483-491, 1999
19. Ward RA, McLeish KR: Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 19:801-807, 1995
20. Ward RA, McLeish KR: Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5:1697-1702, 1995
21. Sedlak J, Lindsay RH: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205, 1968
22. Hu ML, Louie S, Cross CE, et al: Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121:257-262, 1993
23. Riddles PW, Blakely RL, Zerner B: Ellman's reagent: 5,5′-dithiobis (2-nitrobenzoic acid) - A reexamination. Anal Biochem 94:75-81, 1979
24. Buss H, Chan TP, Sluis KB, et al: Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biol Med 23:361-366, 1997
25. Winterbourn CC, Buss IH: Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106-111, 1999
26. des Arg on neutrophil function. Immunopharmacology 2:201-219, 1980
27. Van Epps DE, Garcia ML: Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J Clin Invest 66:167-175, 1980
28. Hoenich NA, Woffindin C, Mathews JNS, Vienken J: Biocompatibility of membranes used in the treatment of renal failure. Biomaterials 16:587-592, 1995
29. Grooteman MPC, Nubé MJ, Van Limbeek J, et al: Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon. ASAIO J 41:215-220, 1995
30. Rhee MS, McGoldrick MD, Meuwissen HJ: Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism. Nephron 42:6-13, 1986
31. Daniels I, Lindsay M, Porter C, et al: Effect of peritoneal dialysis effluent on superoxide anion production by polymorphonuclear neutrophils. Nephron 64:382-387, 1993
32. Daniels I, Fletcher J, Haynes AP: Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent. Clin Diagn Lab Immunol 6:878-884, 1999
33. Hultberg B, Andersson A, Arnadottir M: Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron 70:62-67, 1995
34. Suliman ME, Anderstam B, Lindholm B, Bergström J: Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant 12:2332-2338, 1997
35. Stark GR, Stein WH, Moore S: Reactions with the cyanate present in aqueous urea with amino acids and proteins. J Biol Chem 235:3177-3181, 1960
36. Dirnhuber P, Schulz F: The isometric transformation of urea into ammonium cyanate in aqueous solutions. Biochem J 42:628-632, 1948
37. Lo TWC, Westwood ME, McLellan AC, et al: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, and Nα-acetyllysine, and bovine serum albumin. J Biol Chem 269:32299-32305, 1994
38. Odani H, Shinzato T, Matsumoto Y, et al: Increase in three α,β-dicarbonyl compounds in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 256:89-93, 1999
39. Dean RT, Fu S, Stocker R, Davies MJ: Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1-18, 1997
40. Paul JL, Roch-Arveiller M, Man NK, et al: Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 57:428-432, 1991
41. Chen M-F, Chang C-L, Liou S-Y: Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif 16:290-300, 1998
42. Mimic-Oka J, Simic T, Ekmescic V, Dragicevic P: Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin Nephrol 44:44-48, 1995
43. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al: Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radical Biol Med 21:845-853, 1996
44. Klemm A, Voigt C, Friedrich M, et al: Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance. Nephrol Dial Transplant 16:2166-2171, 2001
45. Svardal AM, Mansoor MA, Ueland PM: Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 184:338-346, 1990
46. Halliwell B, Gutteridge JMC: The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1-8, 1990
47. Hultqvist M, Hegbrant J, Nilsson-Thorell C, et al: Plasma concentrations of vitamin C, vitamin E and/or malondiadehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 47:37-46, 1997
48. Nakayama H, Akiyama S, Inagaki M, et al: Dehydroascorbic acid and oxidative stress in haemodialysis patients. Nephrol Dial Transplant 16:574-579, 2001
49. Soriani M, Pietraforte D, Minetti M: Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys 312:180-188, 1994
50. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358-363, 2001
51. Soejima A, Matsuzawa N, Miyake N, et al: Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol 51:92-97, 1999
52. Owen WF, Lew NL, Liu Y, et al: The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
53. Tarng D-C, Chen TW, Huang T-P, et al: Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 13:1321-1330, 2002
54. Witko-Sarsat V, Friedlander M, Khoa TN, et al: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524-2532, 1998
55. Jacobs AA, Ward RA, Wellhausen SR, McLeish KR: Polymorphonuclear leukocyte function during hemodialysis: Relationship to complement activation. Nephron 52:119-124, 1989
56. Friedman AN, Bostom AG, Levey AS, et al: Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 13:265-268, 2002